发明授权
US07723365B2 Mitotic kinesin inhibitors 失效
有丝分裂驱动蛋白抑制剂

Mitotic kinesin inhibitors
摘要:
The present invention relates to oxadiazoles that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also relates to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
公开/授权文献
信息查询
0/0